Fifteen smokers (10 men) were examined in a 15-week open-label pilot study using psilocybin. After 6 months, 80% of the participants were still abstinent from smoking as determined by biomarker assessment and self-reporting. This far exceeds the cessation rate of <35% for other pharmacological and/or behavioral therapies.
Study Finds Psilocybin is Effective for Treating of Tobacco Addiction
Researchers conduct a safety/feasibility study using psilocybin as an adjunct for quitting smoking.